GELEEN, Netherlands, Nov. 17, 2021 /PRNewswire/ -- Dutch clinical phase biotech Neuroplast raised a total of 10 million (US$ 11.5 million) in funding from investors Lumana Invest, Brightlands Venture Partners, LIOF, and from the Innovation Credit from the Netherlands Enterprise Agency, to further advance the clinical development of a transformative treatment for Traumatic Spinal Cord Injury (TSCI). Neuroplast will use this Series B funding to obtain conditional EMA market approval for its Neuro-Cells stem cell therapy.
Annually, approximately 29,000 people across Europe and the USA suffer from acute Traumatic Spinal Cord Injury (TSCI), for which effective treatment is currently unavailable. Patients usually experience life-long disability and dependence, with a negative impact on quality of life. Furthermore, associated costs for society at large are estimated at over 11.4 billion ($13 billion) per year.
With the aim of giving back perspective to people that suffer from primarily inflammation-driven neurological disorders, Neuroplast has developed Neuro-Cells, a treatment that uses the patient's own stem cells to prevent (further) loss of function during the acute phase after sustaining damage to the spinal cord, to save mobility and independence.
Marcel Kloosterman, Managing Partner at Brightlands Venture Partners (BVP), states:
"The science behind Neuroplast's technology platform is truly groundbreaking.A future in which patients can make smart use of their own cells to put a stop to further neurological damages and improve potential regeneration is getting closer and closer.For BVP it is a thrill to be part of that fascinating journey."
Neuroplast acquired a GMP1 license and received a European Orphan Designation2 that allows fast-track development. Furthermore, it has already successfully completed a clinical Phase I trial, in collaboration with Hospital Nacional de Parapljicos in Spain, that confirmed safety and tolerability, without product-related adverse events. The Dutch Limburg-based biotech is currently preparing for an international multi-center randomized placebo-controlled Phase II study.
Tys van Elk, Director at LIOF, adds:
"Our mission is to move together towards a smarter, more sustainable, and healthier Limburg. We are pleased to see that the life sciences and health ecosystem in Limburg is a successful breeding ground for innovative companies like Neuroplast, that can really make impact."
Neuroplast will use the 10M (US$ 11.5M) Series B funding to take the next steps towards conditional EMA market approval for TSCI, which includes running Phase II and III trials, consulting the EMA and executing a Health Technology Assessment.
Next to the funded pathway for TSCI, Neuroplast aspires to explore applicability of the Neuro-Cellstechnology platform to other therapeutic areas.
Wim Smit, Managing Director at Lumana Invest, comments:
"We are not only excited about the clinical progress of Neuro-Cells treatment for TSCI, but also about the outlook of the technology to other conditions, such as Traumatic Brain Injury."
Vincent The, Chief Financial Officer at Neuroplast, concludes:
"This funding enables us to complete the Neuro-Cells development pathway for TSCI. With the recent successful completion of our Phase I study, we now have both a good clinical as well as a solid financial foundation in place. This puts us in a great position to start exploring the broader potential of the Neuro-Cells technology platform for other primarily inflammation-driven neurological disorders. For these activities, we are seeking complementary investment."
About Traumatic Spinal Cord Injury
Acute TSCI causes incurable impairment to the spinal cord, affecting approximately 12,000 people across Europe and 17,000 across the USA annually. The damage or trauma interrupts communication of the brain with the body regions below the site of injury. Spinal cord injuries are mainly caused by accidents and - in most of the cases - result in life-long loss of control of motor functions and sensations. After the primary injury to the spinal cord, a cascade of events leads to progressive loss of tissue which may further deteriorate the patient's prognosis. Current treatment approaches for TSCI are only symptomatic, leaving the underlying pathophysiology unchanged.
TSCI has a serious impact on the quality of life of patients, with severe implications on mobility and loss of independence. In addition, TSCI creates a lifetime financial burden for patients, payors, healthcare systems and societies at large.
About Neuro-Cells
Neuro-Cells is a transformative treatment under GMP in the crucial first phase after sustaining TSCI, during which the irreversible impact of TSCI can be radically reduced. It contains non-substantially manipulated bone marrow-derived hematopoietic and mesenchymal stem cells, manufactured from a patient's own bone marrow (donor and receiver are the same person). Inflammatory inducing components and pathogens are removed during this process.
About Neuroplast
Neuroplast is a Dutch stem cell technology company focusing on fast-track development programs using autologous cell products for treatment of primarily inflammation-driven neurological disorders, with the aim of giving back perspective to people who suffer from those conditions.
The company was founded in August 2014 by physician Johannes de Munter and neurologist Erik Wolters. Current investors are Lumana Invest, Brightlands Venture Partners, LIOF and the Netherlands Enterprise Agency. Neuroplast is located in Brightlands Chemelot Campus in The Netherlands.
About Lumana Invest
Investment company Lumana was established by entrepreneurs and unique due to not having a predetermined investment horizon. The Lumana founders showcase strong commitment to their portfolio companies by actively supporting management in strategic decision making.
About Brightlands Venture Partners
Brightlands Venture Partners is the fund manager of BVP Fund IV and is a so-called ecosystem investor. BVP invests in companies benefiting from and contributing to the Brightlands campuses in the south of The Netherlands. Other funds under management are Chemelot Ventures, Brightlands Agrifood Fund and Limburg Ventures. BVP Fund IV focuses on sustainability and health and is the successor fund of the 2014 vintage Chemelot Ventures; together the funds have made over 40 investments.
About LIOF
LIOF is the regional development agency for Limburg and supports innovative entrepreneurs with advice, network and financing. Together with entrepreneurs and partners, LIOF is working towards a smarter, more sustainable and healthier Limburg by focusing on the transitions of energy, circularity, health and digitalization.
About The Netherlands Enterprise Agency
The Netherlands Enterprise Agency operates under the auspices of the Dutch Ministry of Economic Affairs and Climate Policy. It facilitates entrepreneurship, improves collaborations, strengthens positions and helps realize national and international ambitions with funding, networking, know-how and compliance with laws and regulations.
Forward looking statements
All statements other than statements of historical facts, including the statements about the clinical and therapeutic potential and future clinical milestones of Neuro-Cells, the indications we intend to pursue and our possible clinical or other business strategies, and the timing of these events, are forward-looking statements. Forward-looking statements can be identified by terms such as "believes", "expects", "plans", "potential", "would" or similar expressions and the negative of those terms. These forward-looking statements are based on our management's current beliefs and assumptions about future events and on information currently available to management. Neuroplast B.V. does not make any representation or warranty, express or implied, as to the improper use of this article, accuracy, completeness or updated status of above-mentioned statements. Therefore, in no case whatsoever will Neuroplast B.V. be legally liable or liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.
In case of any further questions, please contact:
Neuroplast Sasja VerhoogT: +31 (0)85 076 1000E: [emailprotected]
LifeSpring LifeSciences Communication, AmsterdamLeon MelensT: +31 6 538 16 427E: [emailprotected]
1Good Manufacturing Practice (GMP) describes the minimum standards that a medicines manufacturer must meet in their production processes, under inspections coordinated by EMA
2An Orphan Designation (OD) is a designation for treatments of rare conditions, that allows fast-track clinical research
SOURCE Neuroplast
View post:
Dutch stem cell biotech Neuroplast secures 10 million ...
- The global gene therapy market is valued at an estimated USD 7.3 billion in 2022 and is projected to reach USD 17.2 billion by 2027, at a CAGR of... - August 3rd, 2022
- T-cell Lymphoma Market worth $2.89 billion by 2030 - Exclusive Report by InsightAce Analytic - PR Newswire UK - July 17th, 2022
- Cataract Treatment Market Trends, Drivers and Growth Projection Up to 2029 Alcon Vision LLC, Essilor, Ziemer Ophthalmic Systems, Bausch Health,... - July 17th, 2022
- Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) -... - July 17th, 2022
- Religious Groups Official Positions on Stem Cell Research ... - December 8th, 2021
- Regenerative Stem Cells Knee Pain Treatment London, UK ... - December 8th, 2021
- The Case Against Embryonic Stem Cell Research: An ... - December 8th, 2021
- The mTOR Pathway in Pluripotent Stem Cells: Lessons for ... - December 8th, 2021
- Hematopoietic Stem Cell Differentiation Pathways & Lineage ... - December 8th, 2021
- Stem Cell Banking Market Size 2021, Latest Business Opportunities, Growth Statistics, Industry Share, Upcoming Trends, Covid-19 Impact, Demand... - December 8th, 2021
- Removal of sanctions major reason for Iran's signature on JCPOA - Tehran Times - December 8th, 2021
- Primary Cells Market Research Report by Origin, by Cell Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo... - August 4th, 2021
- Global Stem Cell Assay Market growth will help industry players with different potential opportunities to explore the market 2021-2027 The Manomet... - August 4th, 2021
- US trade and investment in Africa - Brookings Institution - August 4th, 2021
- Stem Cell Banking Market Analysis Revealing Key Drivers & Growth Trends through 2029: CCBC, CBR, ViaCord, Esperite, Vcanbio, and others. KSU |... - February 14th, 2021
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Is Expected To Generate Huge Profits and Competitive Outlook - The Courier - February 14th, 2021
- Coronavirus Briefing: What Happened Today - The New York Times - February 6th, 2021
- Global Placental Stem Cells (PSCS) Market 2020: Opportunity and Growth Analysis||LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt.... - February 6th, 2021
- India Cord Stem Cell Banking Market Witness an Outstanding Growth and Strong Revenue and Forecast to 2026 KSU | The Sentinel Newspaper - KSU | The... - January 23rd, 2021
- Global Placental Stem Cells (PSCS) Market Is Expected To Gain Market Growth In The Forecast Period Of 2020 To 2027||ESPERITE NV, LifeCell... - January 23rd, 2021
- Massive Growth Of Bone Marrow Market Size Strong Revenue and Competitive Outlook KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper - January 23rd, 2021
- Stem Cell Characterization Kits Market Trends, Forecast, and Analysis by 2018 to 2026 NeighborWebSJ - NeighborWebSJ - January 23rd, 2021
- Stem Cell Therapy Market 2021-2026 Insights on Type, Region and Comprehensive Analysis of the Development Factors in the Industry Reviewindependent -... - January 23rd, 2021
- Doctor: COVID-19 cases will continue to slowly go down, but were not out of the woods - Yahoo Money - January 23rd, 2021
- Global Blood and Organ Bank Market 2021 Overview, Trends, Growth Factors and Leading Players With Detailed Analysis of Industry Structure The Courier... - January 23rd, 2021
- Global Myelodysplastic syndromes (MDS) Market With COVID 19 Impact Analysis| Leading Players In-depth Analysis Research Report Foresight to 2027 KSU... - January 23rd, 2021
- The 11 most mind-blowing, awe-inspiring health discoveries and innovations of 2020 - Business Insider - Business Insider - December 22nd, 2020
- Cultured Protein: A Guide To Every Cell-Based Meat Startup In The World Right Now - Green Queen Media - December 22nd, 2020
- Comprehensive Report on Animal Stem Cell Therapy Market 2021 | Size, Growth, Demand, Opportunities & Forecast To 2027 | ANIMAL CELL THERAPIES,... - December 22nd, 2020
- Comprehensive Report on Cancer Stem Cell Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Thermo Fisher Scientific, Inc.,... - December 22nd, 2020
- Report On Smart Sensor Market to 2026: (Industry Insights, Company Overview and Investment Analysis) - Farming Sector - December 22nd, 2020
- Latest Study Explores The IVF Market Update 3 Reasons 2021 Could Be The Year Of Great Turnaround - Farming Sector - December 22nd, 2020
- Global Primary Antibodies Market To Reflect Impressive Growth Rate by 2028||Leading Players-Thermo F - PharmiWeb.com - December 22nd, 2020
- Rapper Trae Tha Truth gives back to homeless after Thanksgiving - Yahoo News - December 22nd, 2020
- Haywards Heath woman's bid to fund stem cell treatment to combat MS - Mid Sussex Times - December 14th, 2020
- Regenerative Medicine: Market Trends and Legal Developments on the Horizon for 2021 - MedTech Intelligence - December 14th, 2020
- Worldwide Stem Cell Therapy Market Insights to 2025 - Analysis and Forecasts - GlobeNewswire - December 4th, 2020
- Impact Of Covid-19 on Stem Cell Assay Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 - The Market Feed - December 4th, 2020
- Stem Cells Market is Expected to Thrive at Impressive CAGR by 2025 - The Haitian-Caribbean News Network - December 4th, 2020
- Nobel Prize history from the year you were born - Albany Democrat Herald - December 4th, 2020
- Stem Cell Therapy Market Size, Share, Global Market Research and Industry Forecast Report, 2025 (Includes Business Impact Of Covid-19) - The... - December 4th, 2020
- Stem Cell Assay Market Report 2020 Potential Effect on Upcoming Future Growth by Top Vendors: GE Healthcare, Promega Corporation, Thermo Fisher... - December 4th, 2020
- Transfection Technologies Market Size 2020 | Global Business Strategies, Growing CAGR of 20.0%, Industry Revenue, Opportunities-Aldrich Co Thermo... - December 4th, 2020
- Membrane Filtration Devices Market with COVID-19 Impact, Size 2020, Share, Industry Trends, Future Growth, Regional Overview, Revenue and Forecast... - December 4th, 2020
- Whole Genome Bisulfite Sequencing (WGBS) Market Market To Grow At A CAGR Of 12.90% In The Forecast Period Of 2020 To 2027 | Major Giants Illumina,... - December 4th, 2020
- Global Stem Cell Banking Market to Get Expansion admist COVID 19, Scope With Advanced Technologies Top Key Players and Forecast 2020-2027 - The... - November 28th, 2020
- Scaffold Technology Market Research Report by Product, by Application, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19 -... - November 28th, 2020
- Global Cell Therapy Technologies Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2026 - Cheshire Media - November 28th, 2020
- Global Animal Cell Culture Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2027 by Reportspedia -... - November 28th, 2020
- Global Seed Treatment Fungicides Market 2020 Size Share Upcoming Trends Segmentation And Forecast To 2025 - The Courier - November 28th, 2020
- Stem Cell Source Market Technology Advancements and Business Outlook 2020-2026 - PharmiWeb.com - November 19th, 2020
- Comprehensive Report on Stem Cell Assay Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Bio-Techne Corporation, Promega... - November 19th, 2020
- Cell Therapy Market 2020-2025 Business Strategies JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc.; and Medipost - The Think Curiouser - November 19th, 2020
- Impact Analysis of Covid-19 On Global Stem Cell Assay Market Continues to Expand to Support Development and Top Players: Merck & Co., Thermo... - November 19th, 2020
- Global Cell Expansion Market Size 2020 | Growth Opportunities, Top Leaders, Revenue, Regional Overview and Forecast to 2027 - PRnews Leader - November 19th, 2020
- Primary Cells Market Research Report by Origin, by Cell Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire - November 19th, 2020
- Global Cell and Gene Therapy Market 2020 Key Drivers and Challenges, Opportunities and Forecast Insights by 2025 - KYT24 - November 19th, 2020
- Asset Tracking and Inventory Management Solutions Market outlook by industry size share revenue regions and top key players analysis - The Think... - November 19th, 2020
- DAPT Market to Witness Increase in Revenues by 2020-2028 - The Think Curiouser - November 19th, 2020
- Stem Cell Umbilical Cord Blood Market to Enable the Stakeholders to Capitalize on the Prevailing Industry Opportunities with Investment Analysis By... - October 31st, 2020
- Impact Of Covid 19 On Adult Stem Cells Market 2020 Industry Challenges, Business Overview And Forecast Research Study 2026 - PRnews Leader - October 31st, 2020
- Global Stem Cell Media Market Dynamics Analysis, Production, Supply and Demand, Covered in the Latest Research 2020-2025 - re:Jerusalem - October 31st, 2020
- Comprehensive Report on NK Cell Therapy and Stem Cell Therapy Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Chipscreen... - October 31st, 2020
- Mesenchymal Stem Cells Market Augmented Expansion to Be Registered by 2020-2025 - Eurowire - October 31st, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 with COVID-19 After Effects Growth Drivers, Top Key Players, Industry Segments and Forecast... - October 31st, 2020
- Canine Stem Cell Therapy Market Overview, Development by Companies and Comparative Analysis by 2026 - The Think Curiouser - October 31st, 2020
- Global Adipose Derived Stem Cell Therapy Market 2020 Leading Players, Industry Updates, Comprehensive Analysis and Forecast 2025 - re:Jerusalem - October 31st, 2020
- Outlook on the Regenerative Medicine Global Market to 2025 - Impact of COVID-19 on the Market - GlobeNewswire - October 31st, 2020
- Rising Adoption of Cell Therapy Processing Market by 2020-2027 with Major Giants: BioTime, Inc., Regeneus Ltd., Targazyme, Inc., Bone Therapeutics,... - October 31st, 2020
- Cancer Stem Cells (CSCs) Market to Flourish with an Impressive Cagr During 2020-2027 - The Think Curiouser - October 31st, 2020
- Stem Cell Cryopreservation Equipment Market : In-depth Analysis to Understand the Competitive Outlook of the Global Industry with Future Estimations -... - October 31st, 2020
- Biologics Safety Testing Market : Segmentation, Industry Trends and Development to 2026 - Eurowire - October 31st, 2020
- How Humanity Spent Its First 20 Years in Orbit Aboard the ISS - WIRED - October 31st, 2020
- What to Know in Washington: Provisional Ballots May Play Role - Bloomberg Government - October 31st, 2020
- Impact of COVID-19 on Animal Cell Culture Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Life Technologies, Thermo Fisher,... - October 31st, 2020
- Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Study 2020 Insights with COVID-19 Impact Analysis by 2020Orange... - August 30th, 2020
- Global Cell Isolation Technology Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 - Scientect - August 30th, 2020
- Suramin Sodium Market Projected to Witness a Single-Digit CAGR During 2019-2025 - StartupNG - August 30th, 2020
- Stem Cell Characterization and Analysis Tool Market Growth, Size, Opportunities and Analysis Forecast 2020 - 3rd Watch News - July 12th, 2020
- Ascending Demand for Transient Protein Expression to Propel the Growth of the Transient Protein Expression Market Between 2020-2030 - Cole of Duty - July 12th, 2020